MarketInOut Stock Screener Log In | Sign Up

Sunshine Biopharma Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Sunshine Biopharma Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.21 mln
Float0.17 mln
Earnings Date11/10/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.51
Likely reliable

1-Year Forecast

1,120.00
Transformational upside

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-16%
Loss-making

Business Description

Sunshine Biopharma is a Fort Lauderdale-based company working to develop new treatments for serious diseases, including cancer and viral infections, while also selling a broad range of existing generic medications across the United States and Canada. Its drug pipeline includes treatments targeting pancreatic cancer, liver cancer, and coronavirus infections. The company also sells over-the-counter health products such as amino acid supplements, calcium and vitamin D tablets, and other nutritional items.

Key Fundamentals

EPS-189
ROE-23.91
RPS993
ROIC-33.29
ROA-18.80
EBITDA, mln-5.21
EV / EBITDA2.79
EV / EBIT2.62
Revenue, mln35.35

Quote Details

Last 2.93
Change -0.4 (-12.01%)
Open 3.10
Volume 111,511
Turnover 326,727
Average Volume 814,641

Financial Ratios

Pre-Tax Profit Margin-16
Leverage Ratio1.22
Current Ratio5.46
Price / Book0.01
Price / Tangible Book0.01
Debt / Equity0.03
Price / Sales0.18

Financial Strength

Altman Z-Score-1.78
Piotroski F-Score 4 / 9
Beneish M-Score-2.51
1-Year Target Price1,120.00
Short Ratio0.06
Short % of Float5.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.33% 37 / 100   
1 Month -78.69% 1 / 100   
2 Months -90.42% 1 / 100   
6 Months -98.61% 1 / 100   
1 Year -99.17% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog